Clinical results from a Phase I/IIa trial with the chitosan based adjuvant ViscoGel

Guro Gafvelin, Viscogel joined us last year at the World Vaccine Congress Europe to present on ‘Clinical results from a Phase I/IIa trial with the chitosan based adjuvant ViscoGel’ Download this presentation now to find out more about: ViscoGel® – a viscoelastic hydrogel based on chitosan Unique advantages of ViscoGel as adjuvant Model vaccine for Proof-of-concept studies of ViscoGel as …